VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

REGENXBIO Inc. (RGNX) Total Return Calculator with Dividends Reinvested

REGENXBIO Inc.

Popular:

The total return for REGENXBIO Inc. (RGNX) stock is +43.92% over the past 12 months. So far it's down 23.21% this year. The 5-year total return is -71.27%, meaning $10,000 invested in RGNX stock 5 years ago would be worth $2,873 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in RGNX 1 year ago, it would be worth $14,573 today — you'd have gained $4,573.

With Dividends Reinvested$14,573+45.73%

Price Only (No DRIP)$14,573+45.73%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in RGNX

1Y$14,392+$4,392 (+43.9%)43.9% CAGR

3Y$5,648-$4,352 (-43.5%)-17.3% CAGR

5Y$2,873-$7,127 (-71.3%)-22.1% CAGR

10Y$10,536+$536 (+5.4%)0.5% CAGR

15Y$3,422-$6,578 (-65.8%)-6.9% CAGR

20Y$3,422-$6,578 (-65.8%)-5.2% CAGR

30Y$3,422-$6,578 (-65.8%)-3.5% CAGR

REGENXBIO Inc. did not pay dividends during this period. Total return = price return.

Loading RGNX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-23.21%	—	-23.21%	—	$7,679
1Y	+43.92%	43.92%	+43.92%	—	$14,392
3Y	-43.52%	-17.34%	-43.52%	—	$5,648
5Y	-71.27%	-22.08%	-71.27%	—	$2,873
10Y	+5.36%	0.52%	+5.36%	—	$10,536
15Y	-65.78%	-6.90%	-65.78%	—	$3,422
20Y	-65.78%	-5.22%	-65.78%	—	$3,422
30Y	-65.78%	-3.51%	-65.78%	—	$3,422

Risk & Highlights

Best Year+83.21%2025

Worst Year-57.85%2024

Max Drawdown-51.44%2026-01-22 → 2026-03-27

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-33.38%	-33.38%	—	+0.41%	-33.8pp
2025	+83.21%	+83.21%	—	+16.64%	+66.6pp
2024	-57.85%	-57.85%	—	+24.00%	-81.9pp
2023	-19.33%	-19.33%	—	+24.81%	-44.1pp
2022	-33.90%	-33.90%	—	-19.95%	-14.0pp

RGNX outperformed the S&P 500 by 13.55pp over the past year (+43.92% vs +30.37%).

Loading summary...

RGNX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
RGNXREGENXBIO Inc.	$527M	+18.4%	-23.2%	+43.9%	—	-43.5%	-71.3%	+5.4%
SGMOSangamo Therapeutics, Inc.	$22M	-60.5%	-77.0%	-84.4%	—	-92.0%	-99.0%	-98.4%
RCKTRocket Pharmaceuticals, Inc.	$398M	+5.5%	+6.1%	-45.2%	—	-82.8%	-91.6%	-91.3%
KRYSKrystal Biotech, Inc.	$8.7B	+12.4%	+20.2%	+116.9%	—	+238.5%	+319.2%	+2688.5%
SRPTSarepta Therapeutics, Inc.	$2.2B	-9.9%	-2.4%	-43.4%	—	-83.6%	-72.1%	+18.0%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%
IONSIonis Pharmaceuticals, Inc.	$12.6B	+2.9%	-4.6%	+129.9%	—	+116.1%	+108.0%	+121.1%
ABBVAbbVie Inc.	$358.4B	-1.8%	-10.1%	+11.3%	+3.6pp	+50.4%	+101.3%	+295.5%
REGNRegeneron Pharmaceuticals, Inc.	$73.7B	-6.7%	-8.5%	+27.1%	+0.6pp	-5.1%	+43.6%	+90.0%

Compare:RGNX vs SGMO RGNX vs RCKT RGNX vs KRYS RGNX vs SGMO vs RCKT

About RGNX Dividend Returns

REGENXBIO Inc. (RGNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of RGNX over the past year?

REGENXBIO Inc. (RGNX) delivered a return of 43.92% over the past year. Since RGNX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in RGNX be worth today?

A $10,000 investment in REGENXBIO Inc. one year ago would be worth $14,392 today, representing a gain of $4,392.

Q3Does RGNX pay dividends?

REGENXBIO Inc. (RGNX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RGNX, the total return equals the price-only return.

Q4Did RGNX beat the S&P 500?

Yes, REGENXBIO Inc. (RGNX) outperformed the S&P 500 by 13.55 percentage points over the past year. RGNX delivered a total return of 43.92%, compared to the S&P 500's 30.37%. This 13.55pp alpha means investors in RGNX earned more than a passive S&P 500 index fund.

Q5What is RGNX's worst drawdown?

REGENXBIO Inc. (RGNX) experienced a maximum drawdown of -51.44% over the past year, declining from its peak on 2026-01-22 to its trough on 2026-03-27. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is RGNX's long-term total return over 10, 20, or 30 years?

Here are REGENXBIO Inc. (RGNX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 5.4% (0.5% CAGR) — $10,000 would have grown to $10,536. Over 20 years: -65.8% total return (-5.2% CAGR) — $10,000 → $3,422. Over 30 years: -65.8% total return (-3.5% CAGR) — $10,000 → $3,422. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was RGNX's best and worst year?

REGENXBIO Inc.'s best calendar year was 2025 with a total return of 83.2%. Its worst year was 2024 with a total return of -57.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 141.1 percentage points.